Abstract Search

ba0001op12 | Clinical | ECTS2013

Fracture risk assessment in a primary care population: case finding using routine GP data, FRAX^® And RAIDR^® in the United Kingdom

Aspray Terry , Whalley Erica , Scott Mike , Summers Steve , Turley Steve , Wright Rachel , Maddison Valerie , Abdy Sharon , Kay Lesley

see PP385....

0 shares

ba0001op13 | Clinical | ECTS2013

Hip fracture trends in Denmark 1980–2010 with age-period-cohort-effects

Rosengren Bjorn , Bjork Jonas , Cooper Cyrus , Abrahamsen Bo

see PP380....

0 shares

ba0001op14 | Clinical | ECTS2013

Impact of hip fracture on mortality and life expectancy

Michaelsson Karl , Nordstrom Peter , Nordstrom Anna , Garmo Hans , Byberg Liisa , Pedersen Nancy , Melhus Hakan

see PP381....

0 shares

ba0001op15 | Clinical | ECTS2013

Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density

Pasco Julie , Lane Stephen , Brennan Sharon , Timney Elizabeth , Bucki-Smith Gosia , Dobbins Amelia , Kotowicz Mark

see PP343....

0 shares

ba0001op16 | Clinical | ECTS2013

Long-term effects of symptomatic vs intensive bisphosphonate therapy for Paget's disease of bone: the PRISM-EZ study

Goodman Kirsteen , MacLennan Graeme , Fraser William , Selby Peter , Ralston Stuart

see PP495....

0 shares

ba0001op17 | Clinical | ECTS2013

Denosumab is associated with progressive improvements in hip cortical mass and thickness

Poole K , Treece G , Gee A , Brown J P , McClung M R , Wang A , Libanati C

see PP433....

0 shares

ba0001op18 | Clinical | ECTS2013

Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate- a randomized placebo-controlled trial

Chapurlat Roland , De Villiers Tobias , Bonnick Sydney , Odio Alberto , Palacios Santiago , Scott Boyd , De Tilleghem Celine Le Bailly , DaSilva Carolyn , Leung Albert , Gurner Deborah

see PP446....

0 shares

ba0001op19 | Clinical | ECTS2013

Effects of sclerostin antibody and maintenance of new bone induced by sclerostin antibody in animal models

Li Xiaodong , Ominsky Michael S , Liu Min , Boyce Rogely W , Ke Hua Zhux

see PP447....

0 shares

ba0001op20 | Clinical | ECTS2013

Resolution of effects on bone turnover markers and bone mineral density after discontinuation of long-term bisphosphonate use

Benhamou Claude , De Villiers Tobias , Johnston C Conrad , Langdahl Bente , Saag Kenneth , Denker Andrew , Pong Annpey , McGinnis John P , Rosenberg Elizabeth , Santora Arthur

see PP448....

0 shares

ba0001op21 | Pre-Clinical | ECTS2013

IGF1 regulates MC-3T3 and human primary osteoblast to osteocyte differentiation in 3D culture

Scully Nicole E E , Mason Deborah J , Evans Bronwen A J

see PP245....

0 shares

Bone Abstracts

Fracture risk assessment in a primary care population: case finding using routine GP data, FRAX^® And RAIDR^® in the United Kingdom

Hip fracture trends in Denmark 1980–2010 with age-period-cohort-effects

Impact of hip fracture on mortality and life expectancy

Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density

Long-term effects of symptomatic vs intensive bisphosphonate therapy for Paget's disease of bone: the PRISM-EZ study

Denosumab is associated with progressive improvements in hip cortical mass and thickness

Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate- a randomized placebo-controlled trial

Effects of sclerostin antibody and maintenance of new bone induced by sclerostin antibody in animal models

Resolution of effects on bone turnover markers and bone mineral density after discontinuation of long-term bisphosphonate use

IGF1 regulates MC-3T3 and human primary osteoblast to osteocyte differentiation in 3D culture

BiosciAbstracts